GSK3β and MCL-1 mediate cardiomyocyte apoptosis in response to high glucose

Dongmei Su1,2, Jing Zhao3, Shanshan Hu4

  • 1Department of Genetics, Center for Genetics, Health Department, National Research Institute for Family Planning, 12, Dahuisi Road, Haidian, Beijing, 100081, China.

Insights

Gestational diabetes increases congenital heart defect risk. High glucose induces cardiomyocyte apoptosis via decreased GSK3β (Ser9) phosphorylation and MCL-1 expression, a pathway targeted by SC79.

Area of Science:

  • Cardiovascular Biology
  • Developmental Biology
  • Endocrinology

Background:

  • Gestational diabetes mellitus (GDM) is a significant risk factor for congenital heart defects (CHDs).
  • Hyperglycemia in GDM can lead to decreased myocardial cells and increased apoptosis, contributing to heart abnormalities.
  • The precise mechanisms of high glucose-induced cardiomyocyte apoptosis remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying high glucose-induced cardiomyocyte apoptosis.
  • To investigate the roles of GSK3β (glycogen synthase kinase 3 beta) and MCL-1 (myeloid cell leukemia 1) in this process.
  • To explore potential therapeutic targets for maternal diabetes-induced cardiac abnormalities.

Main Methods:

  • In vitro and in vivo studies using cardiomyocytes and heart tissues from diabetic rat models.
  • Assessment of GSK3β phosphorylation at Ser9 in response to high glucose.
  • Evaluation of the effects of SC79 (Akt pathway activator) and SB216763 (GSK3β inhibitor) on cardiomyocyte apoptosis.
  • Analysis of MCL-1 expression and the impact of its overexpression.

Main Results:

  • High glucose significantly decreased GSK3β phosphorylation on Ser9 in cardiomyocytes, both in vitro and in vivo.
  • SC79 treatment restored GSK3β (Ser9) phosphorylation, while SB216763 exacerbated high glucose-induced apoptosis.
  • A decrease in the anti-apoptotic protein MCL-1 was observed and linked to GSK3β-mediated apoptosis.
  • Overexpression of MCL-1 partially protected cardiomyocytes against high glucose-induced apoptosis.

Conclusions:

  • GSK3β signaling, specifically reduced phosphorylation at Ser9, plays a critical role in high glucose-induced cardiomyocyte apoptosis.
  • MCL-1 acts as a downstream effector in the GSK3β-mediated apoptotic pathway.
  • Targeting the GSK3β/MCL-1 axis may offer therapeutic strategies for preventing cardiac defects associated with maternal diabetes.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
83.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.0K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.3K
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
35.3K